The Effectiveness of a Herbal Supplement in Osteoarthritis.
NCT ID: NCT07324746
Last Updated: 2026-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-12-05
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms.
The supplement will be compared with a placebo.
Participants will:
* take the supplement and placebo for 4 weeks each, one at a time;
* complete validated questionnaires (6 times online)
* perform three performance-based physical tests (6 times online)
* provide a urine sample
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Joint Pain Associated With Osteoarthritis of the Knee With Association of Plant Extracts.
NCT02977936
Turmeric, Black Seeds, Flaxseed and Medicago Sativa in Knee Osteoarthritis
NCT05723458
Flexy3 Supplementation and Joint Health
NCT07349264
Product Responsiveness to Enhanced Bioavailability Curcumin Dietary Supplements in Adults
NCT07196046
Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction
NCT05570123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Treatment
Dietary supplement containing standardised herbal extracts of Boswellia Serrata (525 mg), Curcuma Longa (150 mg), Vitis vinifera (75 mg)
Active treatment
A dietary supplement containing standardised herbal extracts of Boswellia serrata (525 mg), Curcuma longa (150 mg), Vitis vinifera (75 mg). Four times a day.
Placebo
Dietary supplement placebo containing no standardised herbal extracts or other active ingredients.
Placebo
A placebo containing no standardised herbal extracts or other active ingredients. Four times a day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active treatment
A dietary supplement containing standardised herbal extracts of Boswellia serrata (525 mg), Curcuma longa (150 mg), Vitis vinifera (75 mg). Four times a day.
Placebo
A placebo containing no standardised herbal extracts or other active ingredients. Four times a day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of osteoarthritis in knee or hip
* Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours
* Lequesne's Functional Index (LFI) score ≥ 7
* Ambulant patient
Exclusion Criteria
* Autoimmune disease such as rheumatoid arthritis, gout, lupus
* Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage
* Expectation of surgery
* History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months
* Allergy to one of the intervention's ingredients or NSAIDs
* Peptic ulceration and upper gastrointestinal haemorrhage
* High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction
* Tumor, cancer
* Abnormal renal or/and hepatic functions or altered blood chemistry
* Use of concomitant medication able to interfere with the interventions
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Middlesex University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrycja Brodka Pedro
PhD Student in Biomedicine, Bioscience Laboratory Technician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Middlesex Univeristy London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30400
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.